Atopic Dermatitis (Eczema) clinical trials at UCSF

2 research studies open to eligible people

Atopic dermatitis causes dry, itchy areas on the skin. UCSF studies how a treatment called dupilumab interacts with immune cells in affected skin. Another study focuses on sodium in the skin of adults older than 50 years who have eczema.

Showing trials for

  • Molecular Signatures of Cutaneous Dupilumab Response

    open to eligible people ages 18 years and up

    This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.

    San Francisco, California

  • Sodium in the Skin and Atopic Dermatitis

    open to eligible people ages 50 years and up

    The goal of this observational study is to understand factors associated with skin sodium storage in healthy adults and people with atopic dermatitis ages 50 and above. The study is designed to test whether diet and skin barrier function are associated with skin sodium concentration and whether skin sodium concentration is linked to atopic dermatitis and immune profiles over time. Participants will be asked to complete questionnaires, provide bio samples, and undergo non-contrast sodium MRI at 2-3 time points over 3-24 months.

    San Francisco, California and other locations

Our lead scientists for Atopic Dermatitis (Eczema) research studies include .

Last updated: